Akorn Rises On Unusually High Volume (AKRX)

NEW YORK ( TheStreet) -- Akorn (Nasdaq: AKRX) is trading at unusually high volume Monday with 6.4 million shares changing hands. It is currently at 5.1 times its average daily volume and trading up 30 cents (+2.4%) at $12.78 as of 4 p.m. ET.

Akorn has a market cap of $1.07 billion and is part of the health care sector and drugs industry. Shares are up 7.6% year to date as of the close of trading on Friday.

Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic pharmaceutical products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. The company has a P/E ratio of 19.9, above the average drugs industry P/E ratio of 18.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Akorn as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Akorn Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.

If you liked this article you might like

Teva, Mylan Seen to Stay on M&A Sidelines

Merger Buzz Drives Akorn to Top of Health Chart in April

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

European Stocks High on French Perfume and Trump Bump

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More